©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Feb 6, 2025; 13(4): 99637
Published online Feb 6, 2025. doi: 10.12998/wjcc.v13.i4.99637
Published online Feb 6, 2025. doi: 10.12998/wjcc.v13.i4.99637
Imperative for long-term management and surveillance in Kawasaki disease
Yan Pan, Department of Pediatrics, The First Affiliated Hospital of Yangtze University, Jing
Fu-Yong Jiao, Shaanxi Kawasaki Disease Diagnosis and Treatment Center, Children’s Hospital, Shaanxi Provincial People’s Hospital of Xi’an Jiaotong University, Xi’an 710000, Shaanxi Province, China
Author contributions: Jiao FY designed the research study; Pan Y performed the research.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Corresponding author: Fu-Yong Jiao, PhD, Senior Scientist, Shaanxi Kawasaki Disease Diagnosis and Treatment Center, Children’s Hospital, Shaanxi Provincial People’s Hospital of Xi’an Jiaotong University, No. 256 Youyi West Road, Beilin District, Xi’an 710000, Shaanxi Province, China. 3105089948@qq.com
Received: July 26, 2024
Revised: September 27, 2024
Accepted: October 29, 2024
Published online: February 6, 2025
Processing time: 111 Days and 14.4 Hours
Revised: September 27, 2024
Accepted: October 29, 2024
Published online: February 6, 2025
Processing time: 111 Days and 14.4 Hours
Core Tip
Core Tip: Kawasaki disease management requires ongoing surveillance due to the risk of severe coronary artery complications. Consistent follow-up and preventive care are essential for reducing the risk of adverse cardiovascular events in Kawasaki disease patients.